Skip to main content
. 2020 Jul 17;34(3):529–537. doi: 10.1016/j.bpa.2020.07.001

Table 1.

Chronic pain patients' features and challenges of pain treatment outside and during COVID-19 pandemic.

Features of patients with chronic pain Usual therapeutic challenges Challenges during COVID-19 pandemic
Elderly patient Pain assessment and treatment
Greater risk of side effects with NSAIDs and opioids
Greater risk of infection
Caution using opioids or steroids
NSAID and non-NSAIDs (paracetamol, dipyrone), can mask fever and myalgias COVID-19 related
Disabled patient Need of a caregiver to take him to the hospital Risk of infection for him and his caregiver
Multi-morbidity Risk of side effects or less pain control Difficulties with multi-disciplinary team’ evaluation
Multi-treatments Risk of side effects or less pain control Drugs prescription and storage
Cognitive disorders Pain assessment and treatment evaluation Difficulty in remote treatment
Emotional disorders Needing of a biopsychosocial model of pain management.
Patient compliance and adherence to therapy
Worsening of emotional disorders
Worsening compliance to therapy
Adding pandemic-related disorders
High dosages and long-term opioids Risk of endocrine imbalance
Risk of immunosuppression
Risk of respiratory depression
Drugs prescription and storage
Greater risk of infection
Greater risk of respiratory depression during lung infection and with fentanyl patch during fever
Intrathecal Drug Delivery System (ITDDS) Programming pump refill to avoid opioid abstinence syndrome. Need to pump refill to avoid abstinence or to optimize infusion therapy
Neurostimulation implants Periodic checks and programming Need to change exhausted internal battery or surgery for complications or for stage 2 of implant of external leads